Phase II Pilot Study Followed by a Phase III Randomized Study of Lenalidomide Versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma (Lenalidomide Provided) 
ECOG 3A06  (MBMC Contact: Henry Robinson 314-996-5865)  Click For Consent *** (TEMPORARILY SUSPENDED)

***Available through CTSU